Humanigen
Biopharmaceutical company that focuses on developing human antibody therapeutics.
Launch date
Employees
Market cap
€141k
Enterprise valuation
(€20m) (Public information from Jan 2024)
Share price
$0 HGEN
Brisbane California (HQ)
Authorizing premium user...